| Authors: |
Shaw AC; Texas Oncology, 1401 Medical Parkway, Cedar Park, TX, 78613, USA.; University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reilley MJ; University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Medicine, Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA, USA., Nixon B; Program in Writing and Communication, Rice University, Houston, TX, USA., Baile WF; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Epner DE; Department of Palliative, Rehabilitation & Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler, Unit 1414, Houston, TX, 77030, USA. DEpner@mdanderson.org. |